Kyprolis for Combination use in Patients with Relapsed Multiple Myeloma Gets EC Approval
European Commission (EC) provided marketing authorization for Amgen’s Kyprolis® (carfilzomib) in combo with lenalidomide and dexamethasone for the therapy of
Read more